Folic acid (also called folate) is one of the B vitamins (substances essential in very small quantities for nutrition). Leafy vegetables such as spinach and turnip greens, dried beans and peas, avocados, bananas, oranges, and asparagus provide us with natural sources for this vitamin. Folate is essential for the body. It is involved in the synthesis, repair, and normal functioning of DNA (deoxyribonucleic acid—the molecular basis for heredity). Folate is necessary for the production and maintenance of new cells. This is especially important during periods of rapid cell division and growth that occurs during pregnancy and in the development of young children.
The December 13, 2006, issue of JAMA includes an article on folate supplementation and its effect on risk of cardiovascular diseases.
Grahic Jump Location
Prevention of Birth Defects—In 1996, the FDA published regulations requiring the addition of folic acid to enriched breads, cereals, flours, and other grain products. This was specifically targeted to reduce the risk of neural tube defects (malformations of the spinal cord) in newborns. The Centers for Disease Control and Prevention reported in 2004 that since the addition of folic acid to grain-based foods, the rate of neural tube defects has dropped by 25% in the United States.
Prevention of Cancer—Scientific evidence suggests that low blood levels of folate may result in damage to DNA and may lead to cancer. Long-term folic acid supplementation has been shown to be helpful in preventing breast and colon cancers.
Treatment of Noncancerous Diseases—Methotrexate is a powerful drug used to treat a variety of diseases such as rheumatoid arthritis, lupus, psoriasis, asthma, sarcoidosis, and inflammatory bowel disease. It can deplete folate stores and cause side effects that are similar to folate deficiency. Both high-folate diets and supplemental folic acid may help to reduce toxic side effects of methotrexate without decreasing its effectiveness.
Prevention of Heart Disease—Low blood concentrations of folate, vitamin B12, and vitamin B6 may increase the level of homocysteine, an amino acid normally found in the blood. There is evidence that an elevated homocysteine level is an independent risk factor for heart disease and stroke. The effects of folic acid supplementation in lowering the risks of such heart and blood vessel disease are still being evaluated.
Although folic acid is generally accepted as safe, there are concerns that its use as a dietary supplement may have adverse effects in certain groups of individuals. Adverse effects are rare but may include fever, general weakness, shortness of breath, wheezing, tightness in the chest, rash, and itching. There is also a concern that high levels of folate in the blood can mask a vitamin B12 deficiency, which can lead to nerve damage.
National Institutes of Healthhttp://www.cc.nih.gov/ccc/supplements
American Academy of Family Physicianshttp://www.aafp.orghttp://search.familydoctor.org
To find this and previous JAMA Patient pages, go to the Patient Page Index on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on vitamins A to K was published in the June 19, 2002, issue.
Sources: American Academy of Family Physicians, National Institutes of Health
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 203/259-8724.
TOPIC: NUTRITION
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.